Merck & Co as of March 31, 2026
Portfolio Holdings for Merck & Co
Merck & Co holds 14 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 33.6 | $117M | 2.3M | 50.80 | |
| Personalis Ord (PSNL) | 25.6 | $90M | 14M | 6.37 | |
| Kymera Therapeutics (KYMR) | 18.4 | $64M | 772k | 83.29 | |
| Entrada Therapeutics | 6.3 | $22M | 1.7M | 12.62 | |
| Eikon Therapeutics | 5.0 | $18M | 1.7M | 10.58 | |
| Aktis Oncology | 4.9 | $17M | 953k | 17.89 | |
| Alector (ALEC) | 2.2 | $7.6M | 3.5M | 2.15 | |
| Sutro Biopharma | 1.9 | $6.8M | 272k | 24.91 | |
| Evaxion Biotech A/s Sponsored Ads | 1.3 | $4.5M | 1.2M | 3.72 | |
| Miragen Therapeutics (VRDN) | 0.5 | $1.8M | 93k | 19.56 | |
| Xilio Therapeutics | 0.3 | $891k | 106k | 8.41 | |
| Carisma Therapeutics (CARM) | 0.0 | $48k | 1.5M | 0.03 | |
| Neuphoria Therapeutics (NEUP) | 0.0 | $41k | 10k | 4.07 | |
| Tuhura Biosciences (HURA) | 0.0 | $35k | 19k | 1.79 |
